Tech Company Financing Transactions

OrthoAccel Technologies Funding Round

HealthpointCapital Partners, Piper Jaffray Ventures and S3 Ventures participated in a $12 million Series C capital raise for OrthoAccel Technologies. The funding round was announced on 3/11/2016.

Transaction Overview

Announced On
3/11/2016
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series C
Investors
Proceeds Purpose
Continuing to build on another year of dynamic sales growth and market penetration, this investment provides the resources needed to realize our next stage of market share growth. OrthoAccel's expansion plans include aggressive revenue growth internationally and in North America. The company is actively adding 18 new sales representatives, with nine dedicated to expanding direct sales in Europe. Headquartered in Houston, OrthoAccel's growth plans include adding 30 employees to support functions such as marketing, innovation, operations and clinical education.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6575 West Loop South 200
Bellaire, TX 77401
USA
Email Address
Overview
The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
Profile
OrthoAccel Technologies LinkedIn Company Profile
Social Media
OrthoAccel Technologies Company Twitter Account
Company News
OrthoAccel Technologies News
Facebook
OrthoAccel Technologies on Facebook
YouTube
OrthoAccel Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Lowe
  Michael Lowe LinkedIn Profile  Michael Lowe Twitter Account  Michael Lowe News  Michael Lowe on Facebook
Chief Financial Officer
Kelly Enos
  Kelly Enos LinkedIn Profile  Kelly Enos Twitter Account  Kelly Enos News  Kelly Enos on Facebook
Chief Operating Officer
Jeff Layton
  Jeff Layton LinkedIn Profile  Jeff Layton Twitter Account  Jeff Layton News  Jeff Layton on Facebook
VP - Marketing
Kathleen Malaspina
  Kathleen Malaspina LinkedIn Profile  Kathleen Malaspina Twitter Account  Kathleen Malaspina News  Kathleen Malaspina on Facebook
VP - Sales
Doug Bukaty
  Doug Bukaty LinkedIn Profile  Doug Bukaty Twitter Account  Doug Bukaty News  Doug Bukaty on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/11/2016: Bedly venture capital transaction
Next: 3/11/2016: Good Culture venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary